Larvol Delta - 4D-pharma-Presents-Trial-in-Progress-Poster-on-Study-of-MRx0518-in-Combination-with-BAVENCIO-in-Patients-with-Unresectable-Locally-Advanced-or-Metastatic-Urothelial-Carcinoma-at-the-2022-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

Bavencio (avelumab) - EMD Serono, Pfizer

MRx0518 - 4D Pharma

https://www.businesswire.com/news/home/20220526005734/en/4D-pharma-Presents-Trial-in-Progress-Poster-on-Study-of-MRx0518-in-Combination-with-BAVENCIO%C2%AE-in-Patients-with-Unresectable-Locally-Advanced-or-Metastatic-Urothelial-Carcinoma-at-the-2022-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting/

May 26, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next